These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 3060527)

  • 1. Toxoplasmic encephalitis in patients with AIDS.
    Israelski DM; Remington JS
    Infect Dis Clin North Am; 1988 Jun; 2(2):429-45. PubMed ID: 3060527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition and management of toxoplasmosis.
    Heitman BB; Irizarry AF
    Nurse Pract; 1997 Sep; 22(9):75, 79-82, 85-6 passim. PubMed ID: 9314166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of toxoplasmic encephalitis with intravenous clindamycin.
    Dannemann BR; Israelski DM; Remington JS
    Arch Intern Med; 1988 Nov; 148(11):2477-82. PubMed ID: 3190380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group.
    Katlama C; Mouthon B; Gourdon D; Lapierre D; Rousseau F
    AIDS; 1996 Sep; 10(10):1107-12. PubMed ID: 8874627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfadiazine-induced crystalluria in AIDS patients with toxoplasma encephalitis.
    Molina JM; Belenfant X; Doco-Lecompte T; Idatte JM; Modai J
    AIDS; 1991 May; 5(5):587-9. PubMed ID: 1863412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team.
    Luft BJ; Hafner R; Korzun AH; Leport C; Antoniskis D; Bosler EM; Bourland DD; Uttamchandani R; Fuhrer J; Jacobson J
    N Engl J Med; 1993 Sep; 329(14):995-1000. PubMed ID: 8366923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current diagnosis and management of toxoplasmosis in cancer patients.
    McCabe RE
    Oncology (Williston Park); 1990 Oct; 4(10):81-90; discussion 93-4. PubMed ID: 2149827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxoplasmic encephalitis.
    Luft BJ; Fuhrer J
    AIDS Clin Rev; 1990; ():215-34. PubMed ID: 2083178
    [No Abstract]   [Full Text] [Related]  

  • 9. A spectrum in the pathology of toxoplasmosis in patients with acquired immunodeficiency syndrome.
    Bertoli F; Espino M; Arosemena JR; Fishback JL; Frenkel JK
    Arch Pathol Lab Med; 1995 Mar; 119(3):214-24. PubMed ID: 7887774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039.
    Chirgwin K; Hafner R; Leport C; Remington J; Andersen J; Bosler EM; Roque C; Rajicic N; McAuliffe V; Morlat P; Jayaweera DT; Vilde JL; Luft BJ
    Clin Infect Dis; 2002 May; 34(9):1243-50. PubMed ID: 11941551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
    Schürmann D; Bergmann F; Albrecht H; Padberg J; Wünsche T; Grünewald T; Schürmann M; Grobusch M; Vallée M; Ruf B; Suttorp N
    Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insufficient sensitivity of the Toxo-test-MT kit for serodiagnosis of toxoplasmic encephalitis in AIDS patients.
    Suzuki Y; Remington J
    Eur J Clin Microbiol Infect Dis; 1990 Mar; 9(3):238-9. PubMed ID: 2338092
    [No Abstract]   [Full Text] [Related]  

  • 13. [Toxoplasmosis: new aspects, diagnosis and treatment].
    Oksenhendler E; Matheron S
    Rev Prat; 1992 Jan; 42(2):155-9. PubMed ID: 1565998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Issues in toxoplasmosis.
    McCabe R; Chirurgi V
    Infect Dis Clin North Am; 1993 Sep; 7(3):587-604. PubMed ID: 8254161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Brain lesions in patients with acquired immunodeficiency syndrome].
    Repáraz Padrós J; Regalado de los Cobos J; Uriz Ayestarán J
    Enferm Infecc Microbiol Clin; 1991 Feb; 9(2):85-9. PubMed ID: 1854855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinuation of primary and secondary Toxoplasma gondii prophylaxis is safe in HIV-infected patients after immunological restoration with highly active antiretroviral therapy: results of an open, randomized, multicenter clinical trial.
    Miro JM; Lopez JC; Podzamczer D; Peña JM; Alberdi JC; Martínez E; Domingo P; Cosin J; Claramonte X; Arribas JR; Santín M; Ribera E;
    Clin Infect Dis; 2006 Jul; 43(1):79-89. PubMed ID: 16758422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the efficacy and safety of clindamycin plus pyrimethamine for induction and maintenance therapy of toxoplasmic encephalitis in AIDS.
    Katlama C
    Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):189-91. PubMed ID: 2060527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal disseminated hemorrhagic toxoplasmic encephalitis as the initial manifestation of AIDS.
    Wijdicks EF; Borleffs JC; Hoepelman AI; Jansen GH
    Ann Neurol; 1991 Jun; 29(6):683-6. PubMed ID: 1892372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxoplasmosis of the central nervous system in patients with AIDS in Mexico.
    del Rio-Chiriboga C; Orzechowski-Rallo A; Sanchez-Mejorada G
    Arch Med Res; 1997; 28(4):527-30. PubMed ID: 9428578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.